10 million SEK to national study of COVID-19

The Swedish Research Council is providing 10 million SEK to fund the ImmCoVA clinical study. The study is expected to run for three years, and focuses on immune blockers to counteract excess reaction of the immune system to the infection caused by COVID-19.

Foto: Chris McLay, Unsplash

In June, we reported that the Swedish Research Council was to fund Sweden’s participation in the Solidarity trial, a major clinical WHO study, where a number of antiviral medicines are tested on patients being treated for COVID-19. However, due to the high level of mortality seen in patients receiving some of these medicines, the Swedish network for the WHO study decided that Sweden would not participate in the study.

Instead, the Swedish Research Council is now providing the same network of infection clinics in Sweden with funding of 10 million SEK to conduct another national study into COVID-19. The study is called ImmCoVA, and is expected to run for three years, starting in October. The study focuses on immune blockers to counteract excess reaction of the immune system to infection, known as ‘cytokine storm’. The study will investigate whether treatment with two specific immunosuppressing substances can result in improvement, and at best in patients recovering more quickly than with standard treatments.

The Karolinska University Hospital is leading the study, and patients will be recruited from five university hospitals.




  1. The Swedish Research Council establishes national support and advice on health data

    Increased knowledge, national coordination and regular mappings of unclear areas and obstacles. This is the way forward for improving the utilisation of health data for research and innovation. We are now beginning the work of establishing national s...

  2. High quality research into post-COVID syndrome and COVID-19 vaccines

    High quality and good opportunities to contribute to societal benefits summarise the applications approved within the research initiatives for post-COVID syndrome and follow-up studies of COVID-19 vaccines. In relation to studies of COVID-19 vaccines...

  3. Jonas Oldgren appointed Secretary General for Clinical Research

    The Swedish Research Council is appointing a Secretary General for Clinical Research. The position is entirely new, and will be held by Jonas Oldgren, who is a professor in coagulation research, and a senior consultant cardiologist. He will take up h...